- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Senate rejects drug-importation proposal
December 16, 2009
IBJ Staff and Associated PressThe U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers
such as Indianapolis-based Eli Lilly and Co. a victory.
MoreLilly wins approval for long-acting Zyprexa
December 14, 2009
J.K. WallOnce-a-month injection of best-selling drug will have patents that could extend until 2018.
MoreEli Lilly's shares slip after it forecasts mixed profits in coming years
December 10, 2009
IBJ Staff and Associated PressThe Indianapolis-based drugmaker predicts strong profits through 2011, but its forecast for 2012 suggests bottom-line results
could fall precipitously.
MoreLilly launching new venture capital fund
December 10, 2009
J.K. WallThe fund would acquire experimental drugs and use Lilly R&D staff to try to prove their effectiveness, perhaps boosting Lilly's
drug pipeline.
MoreCompany's medical device earns expedited review
December 9, 2009
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing
techniques could begin as early as next year, with commercialization following by 2012.
MoreAriad asks court to restore patent-suit win against Lilly
December 8, 2009
IBJ StaffA federal appeals court will decide whether Eli Lilly and Co. must pay $65.2 million in damages, plus royalties, over a drug-patent
claim.
MorePart of Mississippi's Zyprexa case against Lilly dismissed
December 2, 2009
IBJ StaffIndianapolis-based Eli Lilly and Co. has won a bid to dismiss part of a negligence lawsuit brought by Mississippi that alleges
improper marketing of antipsychotic drug Zyprexa for unapproved uses.
MoreLilly extends research pact with India firm
December 1, 2009
IBJ StaffJubilant Organosys Ltd. and Indianapolis-based Eli Lilly and Co. extended their collaboration, which began in 2005, by five
years.
MoreLilly's Cymbalta wins new approval for anxiety disorder
November 30, 2009
J.K. WallFDA action should boost sales of the Eli Lilly and Co. drug, which were already on pace to top $3 billion this year.
MoreLilly stock droops after rival claims faster-acting impotence pill
November 18, 2009
IBJ StaffCalifornia-based Vivus claims its drug acts in 30 minutes, compared with about 2 hours for Lilly's Cialis.
MoreArcadia sees bigger quarterly loss on lower revenue
November 16, 2009
J.K. WallHealth care company Arcadia Resources Inc. saw growth in pharmacy business, offset by slower medical staffing sales.
MoreAarden Pharmaceuticals chose Indianapolis over San Diego for headquarters
November 14, 2009
IBJ StaffThanks partly to a state grant and support from Indiana’s BioCrossroads life sciences initiative, principals “decided
locating here would give Aarden a better chance of success.
MoreHill-Rom's fourth quarter profit exceeds expectations
November 12, 2009
IBJ StaffThe Batesville-based maker of hospital equipment reported profit of $26.4 million, or 42 cents per share, in the period ended
Sept. 30.
MoreLilly to pay Utah $24 million to settle Zyprexa suit
November 11, 2009
Eli Lilly and Co. has agreed to pay Utah $24 million to settle a lawsuit claiming the company improperly marketed the antipsychotic
drug Zyprexa.
MoreArcadia adds Goldsmith to board, seeks $11M in offering
November 9, 2009
J.K. WallIndianapolis-based Arcadia Resources Inc. has added former Indianapolis Mayor Steve Goldsmith to its board and plans to raise
$11.1 million in a registered direct stock offering.
MoreStruggling Bioanalytical Systems adds outsider to board
November 7, 2009
Peter SchnitzlerShareholders are starting to make inroads in their effort to turn struggling West Lafayette-based Bioanalytical Systems
Inc. in a new direction.
MoreUPDATE: Life science firm to add 100 jobs at Park 100
November 6, 2009
IBJ StaffCalifornia-based life science firm Beckman Coulter Inc. is moving its precision plastics injection molding operation
to the Park 100 business park on Indianapolis' northwest side, making what it calls a multimillion-dollar investment in the
operation.
MoreTechPoint to focus on IT firms specializing in medical, life sciences sectors
October 31, 2009
Chris O'MalleyLong tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.
MoreDoctors balk at Senate attempt to cut out wasteful health care spending
October 31, 2009
IBJ StaffThe big goal of health care reform is to cut wasteful spending to pay for expanded health insurance coverage. But the way
the Senate Finance Committee bill tries to do that would be, according to some doctors, “disastrous.”
MoreLilly opens new biotech center in San Diego
October 29, 2009
J.K. WallLilly is opening the San Diego biotech center a year after launching a biotech R&D center in Indianapolis.
MoreLilly to move 1,000 from Faris campus
October 26, 2009
J.K. WallAs it shrinks its work force, Indianapolis-based pharmaceutical firm Eli Lilly and Co. will move more than 1,000 employees
to its corporate
center
by mid-2010.
MoreCook Group Inc. owner says health reform's tax on medical devices could kill jobs
October 24, 2009
IBJ StaffBloomington-based Cook Group Inc. might have to cut as many as 1,000 local jobs if Congress enacts a tax on medical devices
to pay for health care reform, company founder Bill Cook said in an interview.
MoreLilly settles Zyprexa case with S. Carolina for $45M
October 23, 2009
IBJ Staff and Associated PressSouth Carolina Attorney General Henry McMaster said Friday that the state has reached a $45 million settlement with drug maker
Eli Lilly and Co. over the company's marketing of an anti-psychotic drug.
MoreEli Lilly CEO banking on new drug pipeline
October 22, 2009
Associated PressCEO John Lechleiter says Lilly's pipeline has helped it rebound from significant patent losses three times during his 30-year
career at the company. He's betting there will be a fourth.
MoreZimmer profits fall, but beat expectations
October 22, 2009
J.K. WallThe Warsaw-based company recorded a third-quarter profit of $150 million, down 30 percent from the same quarter a year ago.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
See, I told u Indyman and Dipsicle....this 8 days is overkill. It's barely worth a weekend....great job Tony George! Your dream has been fulfilled....he fans want the I r l back. Thats how good it was.....and that sucked.
I have been in training for a short time now but right off I can see that safety and quality are the number one issues, my experience as of late has been a positive one, the employees along with Jeff the plant manager and the operation supervisor as well as the engineers are a highly motivated group of people, what an asset for the area to have and for company's in need of a quality metal products.
Pimlico
While I understand the severity of their actions as well as everyones eagerness to hold them responsible for thier lost funds, these gentlemen did know how to make money. Dispite thier poor decisions over the ownership of Fair they had made several wise investments which paid them greatly. This proves they do have the potential to rebuild so they can repay. I do not feel they should live the life of luxuary but given an opportunity could they find ways of repaying the debts? They are doing nothing now but being a burden on tax payers. Just a thought!!!!!
You guys have some "interesting" comments to say the least. I hope you will call in and share those opinions starting June 1. I'm looking forward to having you on the air.